Latest Regulatory Compliance News

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.

Takeover chatter lit up Pepper Money, while Identitii ran hard after a regulator stepped in. At the other end, AMP slid despite higher profit, as investors weighed leadership change and legal costs.

Tivan Limited has completed its acquisition of the Baucau and Ossu mineral projects in Timor-Leste and signed a non-binding agreement to form a joint venture with the state-owned Murak Rai. The move positions Tivan at the forefront of mineral exploration in a highly prospective but underexplored region.

Podium Minerals has disclosed the initial securities interests of its newly appointed directors, highlighting a significant allocation of performance rights to Gary Humphries while Neal Froneman holds none.

Finder Energy Holdings has clarified that its recent share price jump is driven by investor enthusiasm around key project milestones, dismissing any undisclosed information as a cause.

Middle Island Resources has revealed extensive polymetallic soil anomalies spanning 5km at its Tisovik target in Serbia’s Bobija Project, signalling a promising expansion of mineralisation. The company plans to intensify exploration activities starting March 2026 to unlock the area’s full potential.

Titanium Sands Limited has responded to ASX inquiries following a sharp share price drop and increased trading volume, confirming no undisclosed price-sensitive information. The company highlighted an unrelated Sri Lankan Supreme Court petition on illegal mining near its pending Mannar Island project.

AMP Limited reported a 20.8% rise in underlying net profit after tax for 2025, driven by growth in wealth platforms and investments, alongside a planned CEO transition and pending class action settlements.

Critical Resources Limited has successfully completed the first tranche of its capital raising, securing $1.605 million through a substantial share and option issuance. The company now awaits shareholder approval for the second tranche, which involves director participation.

Cobre Limited has voluntarily suspended its ASX trading to finalise details of a significant acquisition and placement, with an announcement expected imminently.

Cyclopharm Limited has completed the initial phase of a $14 million share placement, issuing nearly 9.5 million shares at 95 cents each, with the remaining shares set for issuance later this month.

ASB’s half-year results show a modest 1% rise in cash net profit, driven by growth in home, business, and rural lending alongside a 5% increase in customer deposits. The bank is investing heavily in technology, customer experience, and social housing initiatives to support New Zealand’s long-term prosperity.